Cell therapy to help knee cartilage in adults with arthritis
Part of Bones, joints & muscles clinical trials.
This Phase 2 study tests a type of cell treatment aimed at helping recover knee cartilage and improving symptoms from knee osteoarthritis. You may qualify if you have significant knee pain most days, clear arthritis findings on X-rays, and meet medication and medical-history requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 40 to under 60 years old
- Knee pain most days for at least the last month, with pain score 5+ out of 10 in the last 3 months
- Knee osteoarthritis confirmed on recent knee X-rays (Kellgren-Lawrence grade 2 to 4 within the last 12 months)
- Morning stiffness in the affected knee lasts less than 30 minutes, most days
- No use of anti-inflammatory pain medicines (NSAIDs) or blood thinners (anticoagulants) in the last 14 days
- No recent knee procedures or other limiting conditions (no recent steroid/shots into the joint, no arthroscopy in last 6 months; no other study in last year)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether special stem cells (called UC-MSCs, derived from umbilical cord tissue) can reduce pain and improve function in people with moderate knee osteoarthritis. Researchers will inject these cells into your knee to see if they help repair damaged cartilage and reduce inflammation.
This trial tests a new stem cell treatment (NCR100) for knee osteoarthritis. It aims to see if the injection can reduce pain and improve knee function in people with moderate knee OA.
This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.
This study tests a new stem cell treatment for knee osteoarthritis. It aims to see if injecting these cells into the knee can reduce pain and improve function compared to other treatments.
This trial tests a new cell-based treatment (CLS2901C) for knee osteoarthritis. It combines the treatment with a realignment surgery (proximal tibial osteotomy) to help repair cartilage damage and reduce pain.
This trial tests whether a new stem cell treatment, given during a surgical procedure, can help repair damaged cartilage in the knee. It is for people with moderate to severe knee pain and a specific size of cartilage injury.
Hear when a new Knee Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.